Fingolimod (FTY720) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices
- 30 June 2010
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 176 (6), 2682-2694
- https://doi.org/10.2353/ajpath.2010.091234
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research
- Multiple Sclerosis Society of Canada
- National Multiple Sclerosis Society
- Novartis Pharma
This publication has 65 references indexed in Scilit:
- Cyclical and Dose-Dependent Responses of Adult Human Mature Oligodendrocytes to FingolimodThe American Journal of Pathology, 2008
- Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesionsAnnals of Neurology, 2008
- Physiologically Based Pharmacokinetic Modeling of FTY720 (2-Amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in Rats After Oral and Intravenous DosesDrug Metabolism and Disposition, 2006
- Evolution of a neuroprotective function of central nervous system myelinThe Journal of cell biology, 2006
- Interaction between Microglia and Oligodendrocyte Cell Progenitors Involves Golli ProteinsAnnals of the New York Academy of Sciences, 2005
- Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytesExperimental Neurology, 2005
- Lysolecithin induces demyelination in vitro in a cerebellar slice culture systemJournal of Neuroscience Research, 2004
- Characterization of lysophosphatidic acid and sphingosine‐1‐phosphate‐mediated signal transduction in rat cortical oligodendrocytesGlia, 2003
- Nrg-1 Belongs to the Endothelial Differentiation Gene Family of G Protein-coupled Sphingosine-1-phosphate ReceptorsPublished by Elsevier BV ,2001
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998